form10q.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
FORM 10-Q
 
 
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 
For the quarterly period ended September 30, 2009

 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 

For the transition period from

to

Commission file number 001-31922
 
 
TEMPUR-PEDIC INTERNATIONAL INC.
(Exact name of registrant as specified in its charter)
 
Delaware
  
33-1022198
(State or other jurisdiction of
incorporation or organization)
  
(I.R.S. Employer
Identification No.)

 
1713 Jaggie Fox Way
Lexington, Kentucky 40511
(Address, including zip code, of principal executive offices)
 
Registrant’s telephone number, including area code: (800) 878-8889
  
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.905 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes   No

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 
Large accelerated filer x          Accelerated filer o          Non-accelerated filer o
 
(Do not check if a smaller reporting company) Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.): Yes ¨  No x
 
The number of shares outstanding of the registrant’s common stock as of October 23, 2009 was 74,977,377 shares. 
 
 
 
 
 
TABLE OF CONTENTS
 
         
     
  
Page
 
  
 
3
   
  
  
     
 
  
  
   
  
4
   
  
5
   
  
6
   
  
7
     
 
  
21
     
 
  
30
     
 
  
30
   
  
  
     
 
  
31
     
 
  
31
     
 
  
32
     
 
  
32
     
 
  
32
     
 
  
32
     
 
  
32
   
  
33
 
  
  


2

Special Note Regarding Forward-Looking Statements
 
    This quarterly report on Form 10-Q, including the information incorporated by reference herein, contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which include information concerning our plans, objectives, goals, strategies, future events, future revenues or performance, the impact of the macroeconomic environment in both the U.S. and internationally on sales and our business segments, investments in operating infrastructure, our expected capital expenditures, the impact of consumer confidence, the antitrust class action lawsuit and similar issues, pending tax assessments, our financial flexibility and changes to our operating cash flow, the impact of initiatives to accelerate growth, expand market share and attract sales from the standard mattress market, the initiatives to expand business within established accounts, the initiatives to reduce costs and operating expenses and improve manufacturing productivity, the initiatives to improve retail account productivity, our expectations regarding our gross margins, the impact of internet leads, our ability to source raw materials effectively, the development, rollout and market acceptance of new products, changes in our inventory levels, our ability to further invest in the business and in brand awareness, our ability to meet financial obligations and continue to comply with the terms of our credit facility, the effects of our business model, the effects of changes in foreign exchange rates on our reported earnings, our expected sources of cash flow, the effect of foreign tax credits on U.S. income tax liability, our ability to effectively manage cash and our debt/leverage ratio, our ability to align costs with sales expectations and other information that is not historical information. Many of these statements appear, in particular, under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in ITEM 2 of Part I of this report. When used in this report, the words “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes” and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon our current expectations and various assumptions. There can be no assurance that we will realize our expectations or that our beliefs will prove correct.
 
    There are a number of risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements contained in this report. Important factors that could cause our actual results to differ materially from those expressed as forward-looking statements are set forth in this report, including under the heading “Risk Factors” under ITEM IA of Part II of this report and under the heading “Risk Factors” under ITEM 1A of Part 1 of our annual report on Form 10-K for the year ended December 31, 2008. There may be other factors that may cause our actual results to differ materially from the forward-looking statements.
 
    All forward-looking statements attributable to us apply only as of the date of this report and are expressly qualified in their entirety by the cautionary statements included in this report. Except as may be required by law, we undertake no obligation to publicly update or revise any of the forward-looking statements, whether as a result of new information, future events, or otherwise.
 
    When used in this report, except as specifically noted otherwise, the term “Tempur-Pedic International” refers to Tempur-Pedic International Inc. only, and the terms “Company,” “we,” “our,” “ours” and “us” refer to Tempur-Pedic International Inc. and its consolidated subsidiaries.


3
 
PART 1.
 
ITEM 1.
 
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per common share amounts)
(Unaudited)

 
Three Months Ended
  
Nine Months Ended
   
September 30,
      
September 30,
  
   
2009
      
2008
      
2009
      
2008
  
Net sales
$
224,082
    
$
252,814
    
$
586,362
    
$
738,697
  
Cost of sales
  
117,373
      
147,323
      
311,461
      
419,109
  
Gross profit
  
106,709
      
105,491
      
274,901
      
319,588
  
Selling and marketing expenses
  
39,272
      
39,956
      
108,335
      
137,906
  
General, administrative and other expenses
  
24,761
      
22,644
      
68,847
      
73,139
  
Operating income
  
42,676
      
42,891
      
97,719
      
108,543
  
                               
Other expense, net:
                              
Interest expense, net
  
(4,311
)
    
(6,294
)
    
(13,359
)
    
(19,630
)
Other (expense) income, net
  
(214
)
    
96
      
404
      
(995
)
Total other expense
  
(4,525
)
    
(6,198
)
    
(12,955
)
    
(20,625
)
                               
Income before income taxes
  
38,151
      
36,693
      
84,764
      
87,918
  
Income tax provision
  
12,467
      
12,622
      
28,885
      
30,105
  
Net income
$
25,684
    
$
24,071
    
$
55,879
    
$
57,813
  
                               
Earnings per common share:
                              
Basic
$
0.34
    
$
0.32
    
$
0.75
    
$
0.77
  
Diluted
$
0.34
    
$
0.32
    
$
0.74
    
$
0.77
  
                               
Cash dividend per common share
$
—
    
$
0.08
    
$
—
      
0.24
  
                               
Weighted average common shares outstanding:
                              
Basic
  
74,938
      
74,815
      
74,902
      
74,704
  
Diluted
  
76,166
      
74,992
      
75,396
      
74,944
  


See accompanying Notes to Condensed Consolidated Financial Statements. 

4
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
 
 
September 30,
2009
  
December 31,
2008
  
 
(Unaudited)
      
ASSETS
            
             
Current Assets:
            
     Cash and cash equivalents
$
20,003
  
$
15,385
  
     Accounts receivable, net
  
105,397
    
99,811
  
     Inventories
  
48,456
    
60,497
  
     Prepaid expenses and other current assets
  
11,456
    
9,233
  
     Deferred income taxes
  
19,839
    
11,888
  
Total Current Assets
  
205,151
    
196,814
  
             
     Property, plant and equipment, net
  
175,817
    
185,843
  
     Goodwill
  
193,456
    
192,569
  
     Other intangible assets, net
  
65,318
    
66,823
  
     Other non-current assets
  
2,919
    
4,482
  
Total Assets
$
642,661
  
$
646,531
  
             
LIABILITIES AND STOCKHOLDERS’ EQUITY
            
             
Current Liabilities:
            
     Accounts payable
$
46,625
  
$
41,355
  
     Accrued expenses and other current liabilities
  
87,824
    
65,316
  
     Income taxes payable
  
14,533
    
7,783
  
Total Current Liabilities
  
148,982
    
114,454
  
             
     Long-term debt
  
315,000
    
419,341
  
     Deferred income taxes
  
29,142
    
28,371
  
     Other non-current liabilities
  
8,952
    
11,922
  
Total Liabilities
  
502,076
    
574,088
  
             
Commitments and contingencies—see Note 9
            
             
Total Stockholders’ Equity
  
140,585
    
72,443
  
             
Total Liabilities and Stockholders’ Equity
$
642,661
  
$
646,531
  

See accompanying Notes to Condensed Consolidated Financial Statements. 

5
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

 
Nine Months Ended
September 30,
 
2009
  
2008
       
CASH FLOWS FROM OPERATING ACTIVITIES:
              
     Net income
$
55,879
    
$
57,813
  
     Adjustments to reconcile net income to net cash provided by
       operating activities:
              
Depreciation and amortization
  
23,526
      
24,847
  
Amortization of stock-based compensation
  
6,448
      
6,101
  
Amortization of deferred financing costs
  
518
      
888
  
Bad debt expense
  
4,659
      
5,859
  
Deferred income taxes
  
(8,006
)
    
(1,634
)
Foreign currency adjustments
  
53
      
74
  
(Gain) Loss on sale of equipment and other
  
(19
)
    
679
  
Changes in operating assets and liabilities:
  
37,345
      
74,287
  
Net cash provided by operating activities
  
120,403
      
168,914
  
               
CASH FLOWS FROM INVESTING ACTIVITIES:
              
Purchases of property, plant and equipment
  
(8,961
)
    
(7,844
)
Acquisition of businesses, net of cash acquired
  
—
      
(1,529
)
Other
  
(87
)
    
(428
)
          Net cash used by investing activities
  
(9,048
)
    
(9,801
)
               
CASH FLOWS FROM FINANCING ACTIVITIES:
              
Proceeds from long-term revolving credit facility
  
85,797
      
65,429
  
Repayments of long-term revolving credit facility
  
(189,036
)
    
(89,691
)
Repayments of long-term debt
  
—
      
(1,359
)
Repayments of Series A Industrial Revenue Bonds
  
—
      
(57,785
)
Proceeds from issuance of common stock
  
129
      
695
  
Excess tax benefit from stock based compensation
  
—
      
301
  
Dividend paid to stockholders
  
—
      
(17,933
)
Other
  
—
      
(14
)
Net cash used by financing activities
  
(103,110
)
    
(100,357
)
               
NET EFFECT OF EXCHANGE RATE CHANGES ON CASH
  
(3,627
)
    
(4,394
)
               
Increase in cash and cash equivalents
  
4,618
      
54,362
  
               
CASH AND CASH EQUIVALENTS, beginning of period
  
15,385
      
33,315
  
               
CASH AND CASH EQUIVALENTS, end of period
$
20,003
    
$
87,677
  
               
Supplemental cash flow information:
              
     Cash paid during the period for:
              
Interest
$
13,187
    
$
18,960
  
Income taxes, net of refunds
$
28,672
    
$
17,884
  


See accompanying Notes to Condensed Consolidated Financial Statements.

6
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except per common share amounts)
 
(1) Summary of Significant Accounting Policies
 
    (a) Basis of Presentation and Description of Business—Tempur-Pedic International Inc., a Delaware corporation, together with its subsidiaries is a U.S. based, multinational company. The term “Tempur-Pedic International” refers to Tempur-Pedic International Inc. only, and the term “Company” refers to Tempur-Pedic International Inc. and its consolidated subsidiaries. Tempur World, Inc. was formed on January 1, 2000 to combine the manufacturing facilities and the global distribution capabilities of all TEMPUR® products, and Tempur-Pedic International Inc. was formed in 2002 to acquire Tempur World, Inc. This acquisition (Tempur Acquisition) was effective as of November 1, 2002.
 
    The Company manufactures, markets, and sells pillows, mattresses and other related products. The Company manufactures essentially all its pressure-relieving TEMPUR® products at three manufacturing facilities, with one located in Denmark and two in the U.S. The Company has sales distribution subsidiaries operating in the U.S., Europe and Asia Pacific and has third party distribution arrangements in certain other countries where it does not have subsidiaries. The Company sells its products through four sales channels: Retail, Direct, Healthcare and Third party.
 
    The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X and include all of the information and disclosures required by generally accepted accounting principles in the United States (US GAAP) for interim financial reporting. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements of the Company and related footnotes for the year ended December 31, 2008, included in the Company’s annual report on Form 10-K.
 
    The results of operations for the interim periods are not necessarily indicative of results of operations for a full year. It is the opinion of management that all necessary adjustments for a fair presentation of the results of operations for the interim periods have been made and are of a recurring nature unless otherwise disclosed herein.
 
    (b) Accounting Standards Codification—In June 2009, the Financial Accounting Standards Board (FASB) confirmed that the FASB Accounting Standards Codification (FASB ASC) will become the single official source of authoritative US GAAP (other than guidance issued by the Securities and Exchange Commission (SEC)), superseding existing FASB, American Institute of Certified Public Accountants (AICPA), Emerging Issues Task Force (EITF) and related literature. After the FASB ASC became effective (interim and annual periods ending on or after September 15, 2009), only one level of authoritative US GAAP exists. All other literature will be considered non-authoritative. FASB ASC does not change US GAAP; it introduces a new structure that is organized in an easily accessible online research system. The Company adopted FASB ASC beginning in the third quarter of fiscal 2009.
 
    (c) Basis of Consolidation—The accompanying financial statements include the accounts of Tempur-Pedic International and its subsidiaries. All subsidiaries are wholly owned. Intercompany balances and transactions have been eliminated. The Company does not hold any interest in variable-interest entities.
 
    (d) Use of Estimates—The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s results are affected by economic, political, legislative, regulatory and legal actions. Economic conditions, such as recessionary trends, inflation, interest and monetary exchange rates, government fiscal policies and changes in the prices of raw materials, can have a significant effect on operations. While the Company maintains reserves for anticipated liabilities and carries various levels of insurance, the Company could be affected by civil, criminal, regulatory or administrative actions, claims or proceedings.
7
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)–(Continued)
(In thousands, except per common share amounts)
 
    (e) Inventories—Inventories are stated at the lower of cost or market, determined by the first-in, first-out method, and consist of the following:
 
             
   
September 30,
2009
    
December 31,
2008
  
Finished goods
   $ 32,572     $ 41,385  
Work-in-process
     6,920       5,706  
Raw materials and supplies
     8,964       13,406  
    $ 48,456     $ 60,497  
 
(f) Accrued Sales Returns—Estimated sales returns are provided at the time of sale based on historical sales channel return rates. The level of sales returns differs by channel with the Direct channel typically experiencing the highest rate of return.  Estimated future obligations related to these products are provided by a reduction of sales in the period in which the revenue is recognized. The Company allows product returns up to 120 days following a sale through certain sales channels and on certain products. Accrued sales returns are included in Accrued expenses and other current liabilities in the accompanying Condensed Consolidated Balance Sheets.
 
    The Company had the following activity for sales returns from December 31, 2008 to September 30, 2009:

Balance as of December 31, 2008
   $ 3,804  
     Amounts accrued
     23,665  
     Returns charged to accrual
     (23,132 )
Balance as of September 30, 2009
   $ 4,337  
 
    (g) Warranties—The Company provides a 20-year warranty for U.S. sales and a 15-year warranty for non-U.S. sales on mattresses, each prorated for the last 10 years. The Company also provides a two year to three year warranty on pillows. Estimated future obligations related to these products are charged to operations in the period in which the related sale is recognized. Estimates of warranty expenses are based primarily on historical claims experience and product testing. Warranties are included in Accrued expenses and other current liabilities in the accompanying Condensed Consolidated Balance Sheets.
 
    The Company had the following activity for warranties from December 31, 2008 to September 30, 2009:

Balance as of December 31, 2008
   $ 3,903  
     Amounts accrued
     2,432  
     Warranties charged to accrual
     (2,438 )
Balance as of September 30, 2009
   $ 3,897  
 
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)–(Continued)
(In thousands, except per common share amounts)
 
    (h) Revenue Recognition—Sales of products are recognized when persuasive evidence of an arrangement exists, products are shipped and title passes to customers and the risks and rewards of ownership are transferred, the sale price is fixed or determinable and collectability is reasonably assured. The Company extends volume discounts to certain customers and reflects these amounts as a reduction of sales. The Company also reports sales net of tax assessed by qualifying governmental authorities. The Company extends credit based on the creditworthiness of its customers. No collateral is required on sales made in the normal course of business.
 
    The allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in the Company’s existing accounts receivable. The Company regularly reviews the adequacy of its allowance for doubtful accounts. The Company determines the allowance based on historical write-off experience and current economic conditions and also considers factors such as customer credit, past transaction history with the customer and changes in customer payment terms when determining whether the collection of a receivable is reasonably assured. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts included in Accounts receivable, net in the accompanying Condensed Consolidated Balance Sheets was $9,168 and $6,726 as of September 30, 2009 and December 31, 2008, respectively.
 
    (i) Advertising Costs—The Company expenses advertising costs as incurred except for production costs and advance payments, which are deferred and expensed when advertisements run for the first time. Direct response advance payments are deferred and are amortized over the life of the program.
 
    (j) Research and Development Expenses—Research and development expenses for new products are expensed as they are incurred and are included in General, administrative and other expenses. Research and development costs charged to expense were $1,481 and $1,330 for the three months ended September, 2009 and 2008, respectively.  For the nine months ended September 30, 2009 and 2008, research and development costs charged to expense were $4,580 and $4,621, respectively.
 
    (k) Subsequent Events—During the third quarter of fiscal 2009, the Company has evaluated all events or transactions that occurred after September 30, 2009 up through October 26, 2009, the date these condensed consolidated financial statements were issued. During this period, there were no material recognizable or non-recognizable subsequent events.

(2) Goodwill and Other intangible assets
 
    The following summarizes changes to the Company’s Goodwill, by reportable business segment:

   
Domestic
    
International
    
Total
  
Balance as of December 31, 2008
   $ 89,929     $ 102,640     $ 192,569  
Foreign currency translation adjustments
     —       887       887  
Balance as of September 30, 2009
   $ 89,929     $ 103,527     $ 193,456  
                         
 
9
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)–(Continued)
(In thousands, except per common share amounts)
   
    The following table summarizes information relating to the Company’s Other intangible assets:
  
         
September 30, 2009
    
December 31, 2008
  
   
Useful
    
Gross
          
Net
    
Gross
          
Net
  
   
Lives
    
Carrying
    
Accumulated
    
Carrying
    
Carrying
    
Accumulated
    
Carrying
  
   
(Years)
    
Amount
    
Amortization
    
Amount
    
Amount
    
Amortization
    
Amount
  
Unamortized indefinite
  life intangible assets:
                                          
Trademarks
         $ 55,000     $ —     $ 55,000     $ 55,000     $ —     $ 55,000  
                                                       
Amortized intangible
  assets:
                                                      
Technology
     10     $ 16,000     $ 11,067     $ 4,933     $ 16,000     $ 9,866     $ 6,134  
Patents & other
    trademarks
     5-20       11,874       7,932       3,942       11,655       7,767       3,888  
Customer database
     5       4,870       4,568       302       4,838       4,455       383  
Foam formula
     10       3,700       2,559       1,141       3,700       2,282       1,418  
                                                         
            $ 91,444     $ 26,126     $ 65,318     $ 91,193     $ 24,370     $ 66,823  
 
    Amortization expense relating to intangible assets for the Company was $600 and $603 for the three months ended September 30, 2009 and 2008, respectively.  For the nine months ended September 30, 2009 and September 30, 2008 amortization expense relating to intangible assets was $1,810 and $1,810, respectively.
 
(3) Long-term Debt
 
    (a) Long-term Debt—Long-term debt for the Company consists of the following:
 
   
September 30, 2009
    
December 31, 2008
  
2005 Senior Credit Facility:
            
Domestic Long-Term Revolving Credit Facility payable to lenders, interest at Index Rate or LIBOR plus applicable margin (4.59% and 4.44% as of September 30, 2009 and
     December 31, 2008,  respectively), commitment through and due June 8, 2012
   $ 315,000     $ 403,500  
Foreign Long-Term Revolving Credit Facility payable to lenders, interest at Index Rate or LIBOR plus applicable margin (2.59% as of December 31, 2008), commitment through and due June 8, 2012
     —       15,841  
    $ 315,000     $ 419,341  

    (b) Secured Credit Financing—On October 18, 2005, the Company entered into a credit agreement (2005 Senior Credit Facility) with a syndicate of banks. The 2005 Senior Credit Facility, as amended, consists of domestic and foreign credit facilities (Revolvers) that provide for the incurrence of indebtedness up to an aggregate principal amount of $640,000 and matures in 2012. The domestic credit facility is a five-year, $615,000 revolving credit facility (Domestic Revolver). The foreign credit facility is a five-year $25,000 revolving credit facility (Foreign Revolver). The Revolvers provide for the issuance of letters of credit which, when issued, constitute usage and reduce availability under the Revolvers. The aggregate amount of letters of credit outstanding under the Revolvers was $3,748 at September 30, 2009. After giving effect to letters of credit and $315,000 in borrowings under the Domestic Revolver, total availability under the Revolvers was $321,252 as of September 30, 2009. Both credit facilities bear interest at a rate equal to the 2005 Senior Credit Facility’s applicable margin, as determined in accordance with a performance pricing grid set forth in Amendment No. 3, plus one of the following indexes: London Inter-Bank Offering Rate (LIBOR) and for U.S. dollar-denominated loans only, a base rate. The base rate of U.S. dollar-denominated loans is defined as the higher of the Bank of America prime rate or the Federal Funds rate plus ..50%. The Company also pays an annual facility fee on the total amount of the 2005 Senior Credit Facility.  The facility fee is calculated based on the consolidated leverage ratio and ranges from .125% to .25%.
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)–(Continued)
(In thousands, except per common share amounts)
 
    The 2005 Senior Credit Facility is guaranteed by Tempur-Pedic International, as well as certain other subsidiaries of Tempur-Pedic International, and is secured by certain fixed and intangible assets of Dan-Foam ApS and substantially all the Company’s U.S. assets. The 2005 Senior Credit Facility contains certain financial covenants and requirements affecting the Company, including a consolidated interest coverage ratio and a consolidated leverage ratio. The Company was in compliance with all covenants as of September 30, 2009.
 
    In May 2008, the Company entered into a three year interest rate swap agreement to manage interest costs and changing interest rates associated with the 2005 Senior Credit Facility. Refer to Note 5, “Derivative Financial Instruments” for additional information regarding the Company’s derivative instruments, including this interest rate swap.

(4) Fair Value Measurements
 
    Fair Value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset and liability in an orderly transaction between market participants at the measurement date. The Company estimates fair value of its financial instruments utilizing an established three-level hierarchy. The hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date as follows:

·  
Level 1 – Valuation is based upon unadjusted quoted prices for identical assets or liabilities in active markets.
·  
Level 2 – Valuation is based upon quoted prices for similar assets and liabilities in active markets, or other inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instruments.
·  
Level 3 – Valuation is based upon other unobservable inputs that are significant to the fair value measurements.
 
    The classification of fair value measurements within the hierarchy is based upon the lowest level of input that is significant to the measurement.  At September 30, 2009, the Company had an interest rate swap and foreign currency forward contracts recorded at fair value. The fair values of these instruments were measured using valuations based upon quoted prices for similar assets and liabilities in active markets (Level 2) and are valued by reference to similar financial instruments, adjusted for credit risk and restrictions and other terms specific to the contracts. As of September 30, 2009, the Company had no assets or liabilities measured at fair value on a nonrecurring basis. The following tables provide a summary by level of the fair value of assets and liabilities measured on a recurring basis:

     
Fair Value Measurements at September 30, 2009 using:
  
 
September 30, 2009
  
Quoted Prices in Active
Markets for Identical
Assets (Level 1)
  
Significant Other
Observable Inputs (Level 2)
  
Significant
Unobservable Inputs
(Level 3)
  
Liabilities:
                        
Foreign currency forward contracts
   $ 3,688     $ —     $ 3,688     $ —  
Interest rate swap
   $ 8,598     $ —     $ 8,598     $ —  

 
       
Fair Value Measurements at December 31, 2008 using:
  
   
December 31, 2008
  
Quoted Prices in Active
Markets for Identical
Assets (Level 1)
  
Significant Other
Observable Inputs (Level 2)
  
Significant
Unobservable Inputs
(Level 3)
  
Assets:
                        
Foreign currency forward contracts
   $ 96     $ —     $ 96     $ —  
                                 
Liabilities:
                                
Interest rate swap
   $ 11,610     $ —     $ 11,610     $ —  
 
    Borrowings under the 2005 Senior Credit Facility (as defined in Note 3(b)) are at variable interest rates and accordingly their carrying amounts approximate fair value.
11
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)–(Continued)
(In thousands, except per common share amounts)
(5) Derivative Financial Instruments
 
    In the normal course of business, the Company is exposed to certain risks related to fluctuations in interest rates and foreign currency exchange rates. The Company uses various derivative contracts, primarily interest rate swaps and foreign currency exchange forward contracts to manage risks from these market fluctuations. The financial instruments used by the Company are straight-forward, non-leveraged instruments. The counterparties to these financial instruments are financial institutions with strong credit ratings. The Company maintains control over the size of positions entered into with any one counterparty and regularly monitors the credit ratings of these institutions.
 
    The Company is required to recognize all of its derivative instruments as either assets or liabilities in the statement of financial position at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge or a hedge of a net investment in a foreign operation.

Interest Rate Risk
 
    The Company is exposed to changes in interest rates on its 2005 Senior Credit Facility. In order to manage this risk, in May 2008, the Company entered into a three year interest rate swap agreement to manage interest costs and the risk associated with changing interest rates. The Company designated this interest rate swap as a cash flow hedge of floating rate borrowings and expects the hedge to be highly effective in offsetting fluctuations in the designated interest payments resulting from changes in the benchmark interest rate. The gains and losses on the designated swap agreement will offset losses and gains on the transactions being hedged. The Company formally documented the effectiveness of this qualifying hedge instrument (both at the inception of the swap and on an ongoing basis) in offsetting changes in cash flows of the hedged transaction. The fair value of the interest rate swap is calculated as described in Note 4, “Fair Value Measurements” taking into consideration current interest rates and the current creditworthiness of the counterparties or the Company, as applicable.
 
    As a result of this swap, the Company pays at a fixed rate and receives payment at a variable rate. The swap effectively fixed the floating LIBOR-based interest rate to 3.755% on $350,000 of the outstanding balance under the 2005 Senior Credit Facility, with the outstanding balance subject to the swap declining over time. The amount of the outstanding balance subject to the swap declines as follows: to $300,000 on November 28, 2008 (through November, 2009); to $200,000 on November 28, 2009 (through November, 2010); and to $100,000 on November 28, 2010 (through November 28, 2011). The Company will select the LIBOR-based rate on the hedged portion of the 2005 Senior Credit Facility during the term of the swap. The effective portion of the change in value of the swap is reflected as a component of Accumulated other comprehensive loss (OCL) and recognized as Interest expense, net as payments are paid or accrued. The remaining gain or loss in excess of the cumulative change in the present value of the future cash flows of the hedged item, if any (i.e., the ineffectiveness portion) or hedge components excluded from the assessment of effectiveness are recognized as Interest expense, net during the current period.
 
    As of September 30, 2009, the total notional amount of the Company’s interest rate swap agreement is $300,000.  Over the next 12 months, the Company expects to reclassify $6,889 of deferred losses on derivative instruments from Accumulated OCL to earnings due to the payment of variable interest associated with the 2005 Senior Credit Facility.

Foreign Currency Exposures
 
    The Company is exposed to foreign currency risk related to intercompany debt and associated interest payments. To manage the risk associated with fluctuations in foreign currencies, the Company enters into foreign currency forward contracts. The Company does not designate any of these foreign currency forward contracts as hedging instruments, however, the Company considers the contracts as economic hedges. Accordingly, changes in the fair value of these instruments effect earnings during the current period. These foreign currency forward contracts protect against the reduction in value of forecasted foreign currency cash flows resulting from payments in foreign currencies. The fair value of foreign currency agreements are estimated as described in Note 4, “Fair Value Measurements” taking into consideration foreign currency rates and the current creditworthiness of the counterparties or the Company, as applicable.
12
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)–(Continued)
(In thousands, except per common share amounts)
 
    As of September 30, 2009, the Company had foreign currency forward contracts with expiration dates ranging from October 5, 2009 through October 26, 2010. The changes in fair value of these foreign currency hedges are included as a component of Other (expense) income, net. As of September 30, 2009 the Company had the following outstanding foreign currency forward contracts:
 
Foreign Currency
  
Currency Denomination
  
Great Britain Pound
   £
7,326
  
Euros
   €
16,274
  
Japanese Yen
   ¥
441,826
  
Swiss Franc
   fr. 
                    11,092
  
Swedish Krona
   kr. 
                     29,493
  
Norwegian Krona
   kr. 
                       4,275
  
Australian Dollar
   $
1,189
  
New Zealand Dollar
   $
2,067
  
United States Dollar
   $
6,354
  

    As of September 30, 2009 and December 31, 2008, the fair value carrying amount of the Company’s derivative instruments were recorded as follows:

 
Asset Derivatives
  
 
September 30, 2009
  
December 31, 2008
  
 
Balance Sheet Location
  
Fair Value
  
Balance Sheet Location
  
Fair Value
  
Derivatives not designated as hedging instruments
                    
Foreign exchange forward contracts
Prepaid expenses and other current assets
  
$
—
  
Prepaid expenses and other current assets
  
$
96
  
     
$
—
      
$
96
  
 
 
Liability Derivatives
  
 
September 30, 2009
  
December 31, 2008
  
 
Balance Sheet Location
  
Fair Value
  
Balance Sheet Location
  
Fair Value
  
Derivatives designated as hedging instruments
                    
Interest rate swap
Other non-current liabilities
  
$
8,598
  
Other non-current liabilities
  
$
11,610
  
     
$
8,598
      
$
11,610
  
Derivatives not designated as hedging instruments
                    
Foreign exchange forward contracts
Accrued expenses and other current liabilities
  
$
3,688
  
Accrued expenses and other current liabilities
  
$
—
  
                     
     
$
12,286
      
$
11,610
  
 
13
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)–(Continued)
(In thousands, except per common share amounts)
 
    The effect of derivative instruments on the Condensed Consolidated Statement of Income for the three months ended September 30, 2009 was as follows:

Derivatives Designated as Cash Flow Hedging Relationships
  
Amount of (Gain)/Loss
 Recognized in Other Comprehensive Income on
 Derivative
 (Effective Portion)
  
Location of Loss
 Reclassified from
 Accumulated OCL into
 Income
 (Effective Portion)
  
Amount of Loss
 Reclassified from
 Accumulated OCL
 into Income
 (Effective Portion)
  
Location of Loss
 Recognized in Income on
 Derivative (Ineffective
 Portion and Amount
 Excluded from
 Effectiveness Testing)
  
Amount of Loss
 Recognized in Income
 on Derivative
 (Ineffective Portion
 and Amount Excluded
 from Effectiveness Testing)
  
Interest rate swap
  
$
(794)
  
Interest expense, net
  
$
2,445
  
Interest expense, net
  
$
—
  
   
$
(794)
      
$
2,445
      
$
—
  

 
Derivatives Not  Designated as Hedging Instruments
  
Location of (Loss)/Gain
 Recognized in Income on
 Derivative
  
Amount of (Loss)/Gain
 Recognized in Income
 on Derivative
  
Foreign exchange forward contracts
  
Other (expense) income, net
  
$
(222)
  
       
$
(222)
  
 
    For the nine months ended September 30, 2009:
 
Derivatives Designated as Cash Flow Hedging Relationships
  
Amount of (Gain)/Loss
 Recognized in Other Comprehensive  Income on
 Derivative
 (Effective Portion)
  
Location of Loss
 Reclassified from
 Accumulated OCL into
 Income
 (Effective Portion)
  
Amount of Loss
 Reclassified from
 Accumulated OCL
 into Income
 (Effective Portion)
  
Location of Loss
 Recognized in Income on
 Derivative (Ineffective
 Portion and Amount
 Excluded from
 Effectiveness Testing)
  
Amount of Loss
 Recognized in Income
 on Derivative
 (Ineffective Portion
 and Amount Excluded
 from Effectiveness Testing)
  
Interest rate swap
  
$
(3,012)
  
Interest expense, net
  
$
5,991
  
Interest expense, net
  
$
—
  
   
$
(3,012)
      
$
5,991
      
$
—
  
 
Derivatives Not  Designated as Hedging Instruments
  
Location of (Loss)/Gain
 Recognized in Income on
 Derivative
  
Amount of (Loss)/Gain
 Recognized in Income
 on Derivative
  
Foreign exchange forward contracts
  
Other (expense) income, net
  
$
(2,367)
  
       
$
(2,367)
  
 
14
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)–(Continued)
(In thousands, except per common share amounts)
(6) Stockholders’ Equity
 
    (a) Capital Stock—Tempur-Pedic International’s authorized shares of capital stock are 300,000 shares of common stock and 10,000 shares of preferred stock. Subject to preferences that may be applicable to any outstanding preferred stock, holders of the common stock are entitled to receive ratably such dividends as may be declared from time to time by the Board of Directors out of funds legally available for that purpose. In the event of liquidation, dissolution, or winding up, the holders of the common stock are entitled to share ratably in all assets remaining after payment of liabilities, subject to prior distribution rights of preferred stock, if any, then outstanding.
 
    (b) Share Repurchase Programs—On October 16, 2007, the Board of Directors authorized a repurchase authorization of up to $300,000 of the Company’s common stock. Under the existing share repurchase authorization, the Company has $280,100 available for repurchase as of September 30, 2009.  No shares were repurchased during the three or nine months ended September 30, 2009. Share repurchases under this authorization may be made through open market transactions, negotiated purchase or otherwise, at times and in such amounts as the Company and a committee of the Board of Directors deem appropriate. This share repurchase authorization may be suspended, limited or terminated at any time without notice.
 
(7) Other Balance Sheet Items
 
    (a) Property, Plant and Equipment—
 
    Property, plant and equipment, net consists of the following:
 
 
  
September 30, 2009
  
December 31, 2008
  
Land and buildings
  
$
124,829
  
$
122,256
  
Machinery and equipment, furniture and fixtures, and other
  
  
203,257
    
192,029
  
Construction in progress
  
  
6,359
    
5,321
  
 
  
  
334,445
    
319,606
  
Accumulated depreciation
  
  
(158,628
 )  
(133,763
 ) 
 
  
$
175,817
  
$
185,843
  
 
    (b) Accrued expenses and other current liabilities—
 
    Accrued expenses and other current liabilities consisted of the following:

   
September 30, 2009
  
December 31, 2008
  
 
  
            
Salary and related expenses
  
$
15,489
  
$
11,226
  
Accrued sales and value added taxes
    
14,546
    
10,768
  
Accrued unrecognized tax benefits
    
13,589
    
11,012
  
Sales returns
  
  
4,337
    
3,804
  
Warranty accrual
  
  
3,897
    
3,903
  
Other
  
  
35,966
    
24,603
  
 
  
$
87,824
  
$
65,316
  
 
    (c) Accumulated other comprehensive loss—
 
    Accumulated OCL consisted of the following:

 
September 30, 2009
  
December 31, 2008
  
Derivative instruments accounted for as hedges,
     net of tax of $3,353 and $4,528, respectively
$
(5,245
)
$
(7,082
)
Foreign currency translation
  
(2,355
)
  
(5,508
)
Accumulated other comprehensive loss
$
(7,600
)
$
(12,590
)
 
15
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)–(Continued)
(In thousands, except per common share amounts)
    (d) Comprehensive income
 
    The components of comprehensive income consisted of the following:

   
Three Months Ended
    
Nine Months Ended
  
   
September 30,
    
September 30,
  
   
2009
    
2008
    
2009
    
2008
  
                         
Net income
   $ 25,684     $ 24,071     $ 55,879     $ 57,813  
                                 
Derivative instruments accounted for as hedges, net of taxes of $(310), $385, $(1,175) and $832, respectively
     484       (602 )     1,837       (1,301 )
Cumulative translation adjustment
     2,423       (21,249 )     3,152       (9,807 )
Comprehensive income
   $ 28,591     $ 2,220     $ 60,868     $ 46,705  

(8) Stock-Based Compensation
 
    The Company currently has three stock-based compensation plans: the 2002 Option Plan (2002 Plan), the Amended and Restated 2003 Equity Incentive Plan (2003 Plan) and the 2003 Employee Stock Purchase Plan (ESPP), which are described under the caption “Stock-based Compensation” in the notes to the Consolidated Financial Statements of the Company’s Annual Report on Form 10-K for the year ended December 31, 2008.
 
    The Company granted new options to purchase 36 and 1,730 shares of common stock during the three and nine months ended September 30, 2009, respectively. The Company recognized compensation expense of $559 and $1,036 associated with the 2009 grants during the three and nine months ended September 30, 2009, respectively. The Company granted new options to purchase 9 and 2,132 shares of common stock during the three and nine months ended September 30, 2008. The Company recognized compensation expense of $677 and $1,100 associated with the 2008 grants during the three and nine months ended September 30, 2008, respectively. As of September 30, 2009, there was $3,894 of unrecognized compensation expense associated with the options granted in 2009, which is expected to be recorded over the weighted average remaining vesting period of 3.1 years. The options granted in the three months ended September 30, 2009 had a weighted average grant-date fair value of $7.00 per option, as determined by the Black-Scholes option pricing model using the following assumptions:

Expected volatility of stock
  
62.6 – 68.1
%
Expected life of options, in years
  
5.0
  
Risk-free interest rate
  
2.4 – 2.5
%
Expected dividend yield on stock
  
2.2
%
 
    The Company granted 18 new restricted stock units (RSUs) during the three months ended September 30, 2009. There were no RSUs granted in the six months ended June 30, 2009 or the twelve months ended December 31, 2008. The Company recognized compensation expense of $77 with the 2009 RSUs during the three months ended September 30, 2009. As of September 30, 2009, there was $181 of unrecognized compensation expense associated with the RSUs granted in 2009, which is expected to be recorded over the weighted average remaining vesting period of 1.3 years.
 
    The Company recorded $2,355 and $2,060 of total stock-based compensation expense for the three months ended September 30, 2009 and September 30, 2008, respectively.  The Company recorded $6,448 and $6,101 of total stock-based compensation expense for the nine months ended September 30, 2009 and 2008, respectively. 

16
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)–(Continued)
(In thousands, except per common share amounts)
(9) Commitments and Contingencies
 
    (a) Purchase Commitments—The Company will, from time to time, enter into limited purchase commitments for the purchase of certain raw materials. Amounts committed under these programs are not significant as of September 30, 2009.
 
    (b) Antitrust Action—On January 5, 2007, a purported class action was filed against the Company in the United States District Court for the Northern District of Georgia, Rome Division (Jacobs v. Tempur-Pedic International, Inc. and Tempur-Pedic North America, Inc., or the Antitrust Action).  The Antitrust Action alleges violations of federal antitrust law arising from the pricing of Tempur-Pedic mattress products by Tempur-Pedic North America and certain distributors.  The action alleges a class of all purchasers of Tempur-Pedic mattresses in the United States since January 5, 2003, and seeks damages and injunctive relief. Count Two of the complaint was dismissed by the court on June 25, 2007, based on a motion filed by the Company. Following a decision issued by the United States Supreme Court in Leegin Creative Leather Prods., Inc. v. PSKS, Inc. on June 28, 2007, the Company filed a motion to dismiss the remaining two counts of the Antitrust Action on July 10, 2007. On December 11, 2007, that motion was granted and, as a result, judgment was entered in favor of the Company and the plaintiffs’ complaint was dismissed with prejudice. On December 21, 2007, the plaintiffs filed a “Motion to Alter or Amend Judgment,” which has been fully briefed. On May 1, 2008, that motion was denied.  The Jacobs appealed the dismissal of their claims, and the parties argued the appeal before the United States Circuit Court for the Eleventh Circuit on December 11, 2008.  The matter has been taken under advisement by the court.  The Company continues to strongly believe that the Antitrust Action lacks merit, and intends to defend against the claims vigorously. However, due to the inherent uncertainties of litigation, we cannot predict the outcome of the Antitrust Action at this time, and can give no assurance that these claims will not have a material adverse affect on the Company’s financial position or results of operation. Accordingly, the Company cannot make an estimate of the possible ranges of loss.
 
    (c) New York Attorney General—In December 2008, the Office of the Attorney General of the State of New York, Antitrust Bureau (OAG) requested that the Company consider discontinuing its unilateral retail price policy (UPPL) in the State of New York, and informed them that it may bring an enforcement action against the Company under New York law if they chose not to do so. The Office of the Attorney General has made information and document requests of the Company and the Company is cooperating with these requests. The Company believes that its UPPL complies with state and federal law and, should the OAG challenge the UPPL, intends to vigorously defend it. However, due to the inherent uncertainties of this matter, the Company cannot at this time predict the outcome of any such enforcement action, if brought, and can give no assurance that these claims will not have a material adverse affect on its financial position or results of operation.
 
    The Company is involved in various other legal proceedings incidental to the operations of its business. The Company believes that the outcome of all such pending legal proceedings in the aggregate will not have a materially adverse affect on its business, financial condition, liquidity, or operating results.
 
(10) Income Taxes
 
    The Company’s effective tax rate for the nine months ended September 30, 2009 was 34.1%, with reconciling items between the effective tax rate and the federal statutory income tax rate of 35.0% including certain foreign tax rate differentials, state and local income taxes, foreign income currently taxable in the U.S., the production activities deduction, and certain other permanent differences.  For the same period in 2008, the effective tax rate was 34.2% with reconciling items between the effective tax rate and the federal statutory income tax rate of 35.0% including certain foreign tax rate differentials, state and local income taxes, valuation allowances on certain net operating losses, foreign income currently taxable in the U.S., the production activities deduction and certain other permanent differences.
 
    The Company completed the repatriation of certain foreign earnings in the first quarter of 2009. This repatriation was initiated in the fourth quarter of 2008 and the associated income tax expense was recognized at that time. The Company has not provided for U.S. federal and/or state income and foreign withholding taxes on the remaining $112.6 million of undistributed earnings from non-U.S. operations as of September 30, 2009 because the Company intends to reinvest such earnings indefinitely outside of the U. S.  If these earnings were to be distributed, foreign tax credits may become available under current law to reduce the resulting U.S. income tax liability.
 
17
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)–(Continued)
(In thousands, except per common share amounts)
 
    On October 24, 2007, the Company received an income tax assessment from the Danish Tax Authority with respect to the 2001, 2002 and 2003 tax years.  The tax assessment relates to the royalty paid by one of Tempur-Pedic International’s U.S. subsidiaries to a Danish subsidiary and the position taken by the Danish Tax Authority could apply to subsequent years. The total tax assessment is approximately $39.3 million including interest and underpayment premium.  On January 23, 2008 the Company filed timely complaints with the Danish National Tax Tribunal denying the tax assessments.  The National Tax Tribunal formally agreed to place the Danish tax litigation on hold pending the outcome of a Bilateral Advance Pricing Agreement (Bilateral APA) between the United States and the Danish Tax Authority.  A Bilateral APA involves an agreement between the Internal Revenue Service (IRS) and the taxpayer, as well as a negotiated agreement with one or more foreign competent authorities under applicable income tax treaties.  On August 8, 2008 the Company filed the Bilateral APA with the IRS and the Danish Tax Authority. The IRS began analyzing the Bilateral APA in the first quarter of 2009 and expects to finalize its position by the first or second quarter of 2010. The Company believes it has meritorious defenses to the proposed adjustment and will oppose the assessment in the Danish courts, as necessary. It is reasonably possible that the amount of the total unrecognized tax benefits may change in the next twelve months.  An estimate of the amount of such change cannot be made at this time.
 
    The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction and income tax returns in various states and foreign jurisdictions.  With few exceptions, the Company is no longer subject to tax examinations by tax authorities in the U.S. for periods prior to 2006, U.S. state and local municipalities for periods prior to 2004, and in non-U.S. jurisdictions for periods prior to 2001.  Additionally, the Company is currently under examination by various tax authorities around the world.  The Company anticipates it is reasonably possible an increase or decrease in the amount of unrecognized tax benefits could be made in the next twelve months as a result of the statute of limitations expiring and/or the examinations being concluded on these returns.  However, the Company does not presently anticipate that any increase or decrease in unrecognized tax benefits will be material to the consolidated financial statements. During the three and nine months ended September 30, 2009, there were no significant changes to the liability for unrecognized tax benefits.
 
(11) Earnings Per Common Share

   
Three Months Ended
    
Nine Months Ended
  
   
September 30,
    
September 30,
  
   
2009
    
2008
    
2009
    
2008
  
Numerator:
                        
Net income
   $ 25,684     $ 24,071     $ 55,879     $ 57,813  
                                 
Denominator:
                                
Denominator for basic earnings per common share-weighted average shares
     74,938       74,815       74,902       74,704  
Effect of dilutive securities:
                                
     Employee stock options
     1,228       178       494       240  
Denominator for basic earnings per common share-adjusted weighted average shares
     76,166       74,992       75,396       74,944  
                                 
Basic earnings per common share
   $ 0.34     $ 0.32     $ 0.75     $ 0.77  
                                 
Diluted earnings per common share
   $ 0.34     $ 0.32     $ 0.74     $ 0.77  
                                 
 
    The Company excluded 2,039 and 4,932 shares issuable upon exercise of outstanding stock options for the three months ended September 30, 2009 and 2008, respectively, and 4,372 and 3,606 shares issuable upon exercise of outstanding stock options for the nine month periods ended September 30, 2009 and 2008, respectively, from the Diluted earnings per common share computation because their exercise price was greater than the average market price of Tempur-Pedic International’s common stock or they were otherwise anti-dilutive.

18
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)–(Continued)
(In thousands, except per common share amounts)
(12) Business Segment Information
 
    The Company operates in two business segments: Domestic and International. These reportable segments are strategic business units that are managed separately based on the fundamental differences in their operations. The Domestic segment consists of the two U.S. manufacturing facilities, whose customers include the U.S. distribution subsidiary and certain third party distributors in the Americas. The International segment consists of the manufacturing facility in Denmark, whose customers include all of the distribution subsidiaries and third party distributors outside the Domestic segment. The Company evaluates segment performance based on Net sales and Operating income.
 
    The following table summarizes Total assets by segment:

   
September 30, 2009
    
December 31, 2008
  
             
Domestic
   $ 475,746     $ 474,824  
International
     282,702       282,884  
Inter-segment eliminations
     (115,787 )     (111,177 )
    $ 642,661     $ 646,531  

19
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)–(Continued)
(In thousands, except per common share amounts)
 
    The following table summarizes other segment information:

   
Three Months Ended
    
Nine Months Ended
  
   
September 30,
    
September 30,
  
   
2009
    
2008
    
2009
    
2008
  
Net sales from external customers:
                        
     Domestic
                        
           Mattresses
   $ 103,122     $ 121,356     $ 265,133     $ 336,598  
           Pillows
     13,216       14,476       34,090       40,181  
           Other
     29,939       30,056       74,232       85,529  
    $ 146,277     $ 165,888     $ 373,455     $ 462,308  
                                 
     International
                                
           Mattresses
   $ 46,688     $ 53,513     $ 128,149     $ 169,955  
           Pillows
     15,170       16,938       41,363       51,728  
           Other
     15,947       16,475       43,395       54,706  
    $ 77,805     $ 86,926     $ 212,907     $ 276,389  
                                 
    $ 224,082     $ 252,814     $ 586,362     $ 738,697  
                                 
Inter-segment sales:
                                
     Domestic
   $ —     $ —     $ —     $ —  
     International
     686       1,237       1,255       2,347  
     Inter-segment eliminations
     (686 )     (1,237 )     (1,255 )     (2,347 )
    $ —     $ —     $ —     $ —  
                                 
Operating income:
                                
     Domestic
   $ 21,710     $ 21,607     $ 43,737     $ 43,613  
     International
     20,966       21,284       53,982       64,930  
    $ 42,676     $ 42,891     $ 97,719     $ 108,543  
                                 
Depreciation and amortization
   (including stock-based compensation amortization):
                                
     Domestic
   $ 7,979     $ 6,954     $ 22,855     $ 22,785  
     International
     2,388       2,782       7,119       8,163  
    $ 10,367     $ 9,736     $ 29,974     $ 30,948  
                                 
Capital expenditures:
                                
     Domestic
   $ 2,548     $ 1,068     $ 4,636     $ 5,003  
     International
     1,685       448       4,325       2,841  
 
   $ 4,233     $ 1,516     $ 8,961     $ 7,844  
                                 

 
 
    The following discussion and analysis should be read in conjunction with the Condensed Consolidated Financial Statements and accompanying notes included in this Form 10-Q. Unless otherwise noted, all of the financial information in this report is condensed consolidated information for Tempur-Pedic International Inc. or its predecessor. The forward-looking statements in this discussion regarding the mattress and pillow industries, our expectations regarding our future performance, liquidity and capital resources and other non-historical statements in this discussion include numerous risks and uncertainties, as described under “Special Note Regarding Forward-Looking Statements” and “Risk Factors” elsewhere in this quarterly report on Form 10-Q and in our annual report on Form 10-K for the year ended December 31, 2008. Our actual results may differ materially from those contained in any forward-looking statements. Except as may be required by law, we undertake no obligation to publicly update or revise any of the forward-looking statements contained herein.
 
Executive Overview
 
    General—We are the leading manufacturer, marketer and distributor of premium mattresses and pillows which we sell in approximately 80 countries under the TEMPUR® and Tempur-Pedic® brands. We believe our premium mattresses and pillows are more comfortable than standard bedding products because our proprietary pressure-relieving TEMPUR® material is temperature sensitive, has a high density and therapeutically conforms to the body.
 
    Business Segment Information—We have two reportable business segments: Domestic and International. These reportable segments are strategic business units that are managed separately based on the fundamental differences in their operations. The Domestic operating segment consists of our U.S. manufacturing facilities, whose customers include our U.S. distribution subsidiary and certain third party distributors in the Americas. The International segment consists of our manufacturing facility in Denmark, whose customers include all of our distribution subsidiaries and third party distributors outside the Domestic operating segment. We evaluate segment performance based on Net sales and Operating income.

Strategy and Outlook
 
    We believe we are the industry leader in terms of profitability. Our long-term goal is also to become the world’s largest bedding company in terms of revenue. To achieve our long-term goals while managing through the current economic environment, we expect to continue to pursue certain key strategies:
 
 
•
  
Maintain our focus on premium mattresses and pillows and to regularly introduce new products.
 
 
•
  
Invest in increasing our global brand awareness through advertising campaigns that further associate our brand name with better overall sleep and premium quality products.
 
 
•
  
Extend our presence and improve our account productivity in both the Domestic and International Retail segments.
 
 
•
  
Invest in our operating infrastructure to meet the requirements of our business, including investments in our research and development capabilities.

 
•
  
Take actions to further improve our financial flexibility and strengthen the business.

Results of Operations
 
    A summary of our results for the three and nine months ended September 30, 2009 includes the following:
 
•
  
Earnings per common share (EPS) was $0.34 per diluted common share for the three months ended September 30, 2009 as compared to $0.32 per diluted common share for the three months ended September 30, 2008.
 
•
  
Gross profit margin was 47.6% for the three months ended September 30, 2009 compared to 41.7% for the three months ended September 30, 2008.
 
•
  
We reduced total debt by $104.3 million to $315.0 million as of September 30, 2009 from $419.3 million at December 31, 2008.
21
 
(In thousands, except per common share amounts)
  
Three Months Ended
September 30,
    
Nine Months Ended
September 30,
  
   
2009
    
2008
    
2009
    
2008
  
Net sales
   $ 224,082       100.0 %   $ 252,814       100.0 %   $ 586,362       100.0 %   $ 738,697       100.0 %
Cost of sales
     117,373       52.4       147,323       58.3       311,461       53.1       419,109       56.7  
                                                                 
Gross profit
     106,709       47.6       105,491       41.7       274,901       46.9       319,588       43.3  
Selling and marketing expenses
     39,272       17.5       39,956       15.8       108,335       18.5       137,906       18.7  
General, administrative and other expenses
     24,761       11.0       22,644       9.0       68,847       11.7       73,139       9.9  
                                                                 
Operating income
     42,676       19.1       42,891       17.0       97,719       16.7       108,543       14.7  
                                                                 
Interest expense, net
     (4,311 )     (1.9 )     (6,294 )     (2.5 )     (13,359 )     (2.3 )     (19,630 )     (2.7 )
Other (expense) income, net
     (214 )     (0.1 )     96       —       404       0.1       (995 )     (0.1 )
                                                                 
Income before income taxes
     38,151       17.1       36,693       14.5       84,764       14.5       87,918       11.9  
Income tax provision
     12,467       5.6       12,622       5.0       28,885       4.9       30,105       4.1  
Net income
   $ 25,684       11.5 %   $ 24,071       9.5 %   $ 55,879       9.6 %   $ 57,813       7.8 %
                                                                 
Earnings per common share:
                                                                
Basic
   $ 0.34             $ 0.32             $ 0.75             $ 0.77          
Diluted
   $ 0.34             $ 0.32             $ 0.74             $ 0.77          
Cash dividend per common share:
   $ —             $ 0.08             $ —             $ 0.24          
Weighted average common shares outstanding:
                                                                
Basic
     74,938               74,815               74,902               74,704          
Diluted
     76,166               74,992               75,396               74,944          

Three Months Ended September 30, 2009 Compared with Three Months Ended September 30, 2008
 
    We sell our premium mattresses and pillows through four distribution channels: Retail, Direct, Healthcare, and Third party. The Retail channel sells to furniture and bedding, specialty and department stores. The Direct channel sells directly to consumers. The Healthcare channel sells to hospitals, nursing homes, healthcare professionals and medical retailers. The Third party channel sells to distributors in countries where we do not operate our own wholly-owned subsidiaries. A summary of Net sales by channel is below:

   
CONSOLIDATED
    
DOMESTIC
    
INTERNATIONAL
  
   
Three Months Ended
    
Three Months Ended
    
Three Months Ended
  
   
September 30,
    
September 30,
    
September 30,
  
(In thousands)
  
2009
  
2008
    
2009
  
2008
    
2009
  
2008
  
Retail
   $ 191,012   $ 216,226     $ 129,883   $ 147,992     $ 61,129   $ 68,234  
Direct
     12,245     11,230       10,600     9,169       1,645     2,061  
Healthcare
     8,942     11,636       2,804     3,727       6,138     7,909  
Third party
     11,883     13,722       2,990     5,000       8,893     8,722  
    $ 224,082   $ 252,814     $ 146,277   $ 165,888     $ 77,805   $ 86,926  
 
22
    A summary of Net sales by product is below:

   
CONSOLIDATED
    
DOMESTIC
    
INTERNATIONAL
  
   
Three Months Ended